DJO, Exos ink distribution agreement

DJO Global has inked an exclusive distribution agreement with Exos Corporation. Under the terms of the deal, DJO will have exclusive rights to sell Exos' range of upper extremity products that incorporate the latter's thermoformable polymer technology in North and South America. Terms of the distribution agreement were not disclosed. DJO release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.